Ocugen Inc (NASDAQ:OCGN) - Share price


Stock Report

Ocugen Inc OCGN

Last Price
$10.91

Day Change
-1.60|-12.79%

As of 05/05/2021
19:59:59 EDT | USD
Minimum 15 Minutes Delay.

Last Close12.51
Day Range10.88 - 13.75
Mkt Cap2.05Bil
52-Wk Range0.17 - 18.77
Yield %-
ISINUS67577C1053
Volume95,972,538
P/E2.51
P/SInfinity
P/CF-83.22

Share Price

Financials
201820192020
More ...
Income Statement
Revenue0.000.000.04
Operating Income-25.84-14.16-21.28
Net Income-8.64-20.24-21.82
Basic EPS-13.80-1.46-0.31
Avg. Diluted Shares Outstanding114112
Balance Sheet
Current Assets16.4015.7725.88
Non Current Assets1.031.041.50
Total Assets17.4316.8127.38
Current Liabilities2.874.543.61
Total Liabilities17.895.795.83
Total Equity-0.4611.0221.55
Cash Flow
Operating Cash Flow-15.78-16.89-14.71
Capital Expenditure-2.01-0.03-0.31
Free Cash Flow-17.79-16.92-15.02

In millions, except "Basic EPS". Currency is USD.

Company Profile

Ocugen Inc is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. Ocugen offers a diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules and targets a broad range of high-need retinal and ocular surface diseases. Its product candidate includes OCU200 and OCU300 to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet age-related macular degeneration (AMD).

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Value

Fiscal Year Ends

December

Employees

15
Key Stats
More ...
Price/Earning TTM-40.35
Price/Book109.26
Price/Sales TTM31,275.00
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % TTM-49,940.68
Net Margin % TTM-51,201.20
ROE TTM-211.05
Debt/Equity0.10
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2021 Morningstar. All rights reserved.